Tuesday, 24 March 2026
  
Login

Australia's most trusted
source of pharma news

Tuesday, 24 March 2026
News

Fresh fallout from PBAC rejections

Posted 23 March 2026 AM

The onslaught of PBAC rejections is taking a human toll beyond patients, with distress levels also rising for Australian pharma employees, according to industry coach and best-selling author, Paula Fenwick.

She said while patients have the most to lose, pharma teams are also feeling the fallout - from resubmission pressures and a sense of failure to job security fears. For companies, every rejection or deferral ties up capital and strains budgets.

To see the whole article, please login


Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.